Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$56.68 B
Marketcap
$441.51
Share price
-0.48%
Change (1 day)
45.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of June 2024 : NZ$4.24 B

According to Alnylam Pharmaceuticals 's latest financial reports the company has NZ$4.24 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$3.85 B11.7%
2022-12-31NZ$3.45 B-2.9%
2021-12-31NZ$3.55 B36.46%
2020-12-31NZ$2.60 B14.45%
2019-12-31NZ$2.27 B40.96%
2018-12-31NZ$1.61 B-32.13%
2017-12-31NZ$2.38 B163.07%
2016-12-31NZ$0.90 B-42.75%
2015-12-31NZ$1.58 B77.97%
2014-12-31NZ$0.88 B196.66%
2013-12-31NZ$0.29 B99.85%
2012-12-31NZ$0.14 B-20.14%
2011-12-31NZ$0.18 B-38.17%
2010-12-31NZ$0.30 B-22.26%
2009-12-31NZ$0.39 B-47.68%
2008-12-31NZ$0.74 B47.83%
2007-12-31NZ$0.50 B63.64%
2006-12-31NZ$0.30 B163.47%
2005-12-31NZ$0.11 B81.38%
2004-12-31NZ$64.53 M80.87%
2003-12-31NZ$35.67 M20.65%
2002-12-31NZ$29.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.70 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.85 B 273.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.36 B-44.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$65.58 M-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.63 B 221.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$11.77 B 177.53%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$3.64 B-13.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel